These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6707690)

  • 21. Myoglobin RIA in detecting carriers of Duchenne's muscular dystrophy.
    Sabria-Leal M; Gimeno-Leal JM; Paret-Masana A; Rey-Joly Barroso C
    Eur Neurol; 1986; 25(4):253-5. PubMed ID: 3720800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.
    Diószeghy P; Mechler F
    J Neurol; 1988 Jan; 235(3):174-6. PubMed ID: 3367167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy.
    Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ
    N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925
    [No Abstract]   [Full Text] [Related]  

  • 24. Prenatal diagnosis in Duchenne muscular dystrophy: Salvage of normal male fetus.
    Dubowitz V; van Iddekinge B; Rodeck CH; Campbell S; Singer JD; Scheuerbrandt G; Moss DW
    Lancet; 1978 Jan; 1(8055):90. PubMed ID: 74582
    [No Abstract]   [Full Text] [Related]  

  • 25. [A study of carrier detection of Duchenne type progressive muscular dystrophy by serum myoglobin measurement (author's transl)].
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    Rinsho Shinkeigaku; 1982 Jan; 22(1):30-5. PubMed ID: 7094482
    [No Abstract]   [Full Text] [Related]  

  • 26. Fetal serum-creatine-phosphokinase not a valid predictor of Duchenne muscular dystrophy.
    Ionasescu V; Zelleger H; Cancilla P
    Lancet; 1978 Dec; 2(8102):1251. PubMed ID: 82752
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal diagnosis of Duchenne muscular dystrophy.
    Emery AE; Burt D; Dubowitz V; Rocker I; Donnai D; Harris R; Donnai P
    Lancet; 1979 Apr; 1(8121):847-9. PubMed ID: 86094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal plasma carbonic anhydrase III and creatine kinase in Duchenne dystrophy.
    Heath R; Carter N; Jeffery S; Edwards R; Watts D; Watts R; Rodeck C
    Ann N Y Acad Sci; 1984; 429():620-3. PubMed ID: 6430200
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for Duchenne muscular dystrophy.
    Dubowitz V
    Arch Dis Child; 1976 Apr; 51(4):249-51. PubMed ID: 776092
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 33. Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection.
    Adornato BT; Kagen LJ; Engel WK
    Lancet; 1978 Sep; 2(8088):499-501. PubMed ID: 79868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duchenne muscular dystrophy: early diagnosis, and screening.
    Arch Dis Child; 1976 Dec; 51(12):982-6. PubMed ID: 1015854
    [No Abstract]   [Full Text] [Related]  

  • 36. In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus "suddenly at risk".
    Evans MI; Farrell SA; Greb A; Ray P; Johnson MP; Hoffman EP
    Am J Med Genet; 1993 May; 46(3):309-12. PubMed ID: 8488877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST; Nagy B; Samaha FJ
    J Child Neurol; 1987 Jan; 2(1):17-21. PubMed ID: 3624824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
    Moser H
    Hum Genet; 1984; 66(1):17-40. PubMed ID: 6365739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systematic neonatal screening for Duchenne muscular dystrophy].
    Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
    Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.